These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 31195398

  • 1. miR-130b Promotes Sunitinib Resistance through Regulation of PTEN in Renal Cell Carcinoma.
    Sekino Y, Sakamoto N, Sentani K, Oue N, Teishima J, Matsubara A, Yasui W.
    Oncology; 2019; 97(3):164-172. PubMed ID: 31195398
    [Abstract] [Full Text] [Related]

  • 2. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T, Cao R, Li S, Fu M, Ren L, Chen W, Zhu H, Zhan Q, Shi R.
    BMC Cancer; 2015 Jan 31; 15():29. PubMed ID: 25637514
    [Abstract] [Full Text] [Related]

  • 3. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z, Chang X, Zhu G, Gao X, Chang L.
    Cell Cycle; 2020 Aug 31; 19(16):2054-2062. PubMed ID: 32663095
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X, Xin S, He Z, Che X, Wang J, Xiao X, Chen J, Song X.
    Cell Physiol Biochem; 2014 Aug 31; 33(6):1631-42. PubMed ID: 24902663
    [Abstract] [Full Text] [Related]

  • 5. PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma.
    Sekino Y, Hagura T, Han X, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Shigeta M, Taniyama D, Kuraoka K, Sentani K, Yasui W, Matsubara A.
    Anticancer Res; 2020 Apr 31; 40(4):1943-1951. PubMed ID: 32234883
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene.
    Sun X, Lou L, Zhong K, Wan L.
    Exp Biol Med (Maywood); 2017 Jun 31; 242(12):1299-1305. PubMed ID: 28429654
    [Abstract] [Full Text] [Related]

  • 9. miR-96-5p targets PTEN to mediate sunitinib resistance in clear cell renal cell carcinoma.
    Park SE, Kim W, Hong JY, Kang D, Park S, Suh J, You D, Park YY, Suh N, Hwang JJ, Kim CS.
    Sci Rep; 2022 Mar 03; 12(1):3537. PubMed ID: 35241735
    [Abstract] [Full Text] [Related]

  • 10. Circular RNA circSNX6 promotes sunitinib resistance in renal cell carcinoma through the miR-1184/GPCPD1/ lysophosphatidic acid axis.
    Huang KB, Pan YH, Shu GN, Yao HH, Liu X, Zhou M, Wei JH, Chen ZH, Lu J, Feng ZH, Chen W, Han H, Zheng ZS, Luo JH, Zhang JX.
    Cancer Lett; 2021 Dec 28; 523():121-134. PubMed ID: 34626691
    [Abstract] [Full Text] [Related]

  • 11. Identification of MicroRNAs Involved in Resistance to Sunitinib in Renal Cell Carcinoma Cells.
    Yamaguchi N, Osaki M, Onuma K, Yumioka T, Iwamoto H, Sejima T, Kugoh H, Takenaka A, Okada F.
    Anticancer Res; 2017 Jun 28; 37(6):2985-2992. PubMed ID: 28551636
    [Abstract] [Full Text] [Related]

  • 12. Uc.416 + A promotes epithelial-to-mesenchymal transition through miR-153 in renal cell carcinoma.
    Sekino Y, Sakamoto N, Goto K, Honma R, Shigematsu Y, Quoc TP, Sentani K, Oue N, Teishima J, Kawakami F, Karam JA, Sircar K, Matsubara A, Yasui W.
    BMC Cancer; 2018 Oct 04; 18(1):952. PubMed ID: 30286729
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H, Chen B, Duan B, Zheng J, Wu X.
    Mol Med Rep; 2016 Oct 04; 14(4):3343-9. PubMed ID: 27498834
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
    Liu Y, Cheng G, Huang Z, Bao L, Liu J, Wang C, Xiong Z, Zhou L, Xu T, Liu D, Yang H, Chen K, Zhang X.
    Cell Death Dis; 2020 Jul 08; 11(7):515. PubMed ID: 32641718
    [Abstract] [Full Text] [Related]

  • 17. Expressions of miR-96-5p, miR-29b-3p, and Their Target Gene THBS1 in Clear Cell Renal Cell Carcinoma and Sunitinib Resistance.
    Wu S, Wang Y.
    Altern Ther Health Med; 2024 Jul 08; 30(7):268-273. PubMed ID: 37971460
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
    Miao Y, Zheng W, Li N, Su Z, Zhao L, Zhou H, Jia L.
    Sci Rep; 2017 Feb 06; 7():41942. PubMed ID: 28165066
    [Abstract] [Full Text] [Related]

  • 19. Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinoma.
    D'Costa NM, Lowerison MR, Raven PA, Tan Z, Roberts ME, Shrestha R, Urban MW, Monjaras-Avila CU, Oo HZ, Hurtado-Coll A, Chavez-Munoz C, So AI.
    J Exp Clin Cancer Res; 2020 Feb 10; 39(1):33. PubMed ID: 32041631
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis.
    Zeng X, Hu Z, Ke X, Tang H, Wu B, Wei X, Liu Z.
    Cell Cycle; 2017 Feb 10; 16(22):2212-2219. PubMed ID: 28881158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.